Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Posted On Monday, August 04, 2025
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
Posted On Monday, August 04, 2025
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
Posted On Monday, August 04, 2025
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
Posted On Monday, August 04, 2025
Ardelyx Announces Changes to the Executive Leadership Team
Posted On Monday, August 04, 2025
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference
Posted On Monday, August 04, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Posted On Monday, August 04, 2025
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Monday, August 04, 2025
Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025
Posted On Monday, August 04, 2025
FibroGen to Report Second Quarter 2025 Financial Results
Posted On Monday, August 04, 2025
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
Posted On Monday, August 04, 2025
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Monday, August 04, 2025
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Monday, August 04, 2025
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
Posted On Monday, August 04, 2025
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
Posted On Monday, August 04, 2025
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models
Posted On Monday, August 04, 2025
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
Posted On Monday, August 04, 2025
Corporate Update, August 2025
Posted On Monday, August 04, 2025
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
Posted On Monday, August 04, 2025
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
Posted On Monday, August 04, 2025
New Way to Take Iron: IBSA Launches Innovative Orally Dissolving Film Supplement That’s Gentle on the Stomach and Easy to Take
Posted On Monday, August 04, 2025
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
Posted On Monday, August 04, 2025
Sirona Biochem Update to Shareholders on Financial Status and Operations
Posted On Friday, August 01, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 01, 2025
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 01, 2025

First page
Previous page
…
3
4
5
6
7
8
9
10
11
…
Next page
Last page

Print